A case of autoimmune-related retinopathy and optic neuropathy syndrome treated by autologous nonmyeloablative hematopoietic stem cell transplantation

Journal of Neuro-Ophthalmology

Volumn 29, Issue 1, 2009, Pages 43-49

  Oyama, Yu ^a   Burt, Richard K ^a   Thirkill, Charles ^b   Hanna, Eissa ^b   Merrill, Kevin ^b   Keltner, John ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

ADULT; ANAMNESIS; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNE RELATED RETINOPATHY AND OPTIC NEUROPATHY SYNDROME; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; ENT EXAMINATION; FEMALE; HUMAN; LABORATORY TEST; NEUROLOGIC EXAMINATION; OPHTHALMOSCOPY; OPTIC NERVE DISEASE; PERCEPTION DEAFNESS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RETINOPATHY; VESTIBULAR DISORDER; VISUAL ACUITY; VISUAL IMPAIRMENT;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; BLOTTING, WESTERN; ELECTRORETINOGRAPHY; EYE PROTEINS; FEMALE; HEARING DISORDERS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; OPTIC NERVE DISEASES; PERIMETRY; RETINAL DISEASES; SYNDROME; TRANSPLANTATION, AUTOLOGOUS; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS;

EID: 68049101346     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNO.0b013e318199becf     Document Type: Article

References (46)

1. Keltner JL, Thirkill CE, Huynh PM. Autoimmune-related retinopathy and optic neuropathy (ARRON) syndrome (Abstract). J Neuroophthalmol 2002;22:160-161
2. Adamus G, Chan CC. Experimental autoimmune uveitides: multiple antigens, diverse diseases. Int Rev Immunol 2002;21:209-229 (Pubitemid 34791941)
3. Mizener JB, Kimura AE, Adamus G, et al. Autoimmune retinopathy in the absence of cancer. Am J Ophthalmol 1997;123:607-618
4. Keltner JL, Roth AM, Chang RS. Photoreceptor degeneration: possible autoimmune disorder. Arch Ophthalmol 1983;101:564-569
5. Adamus G, Webb S, Shiraga S, et al. Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells. J Autoimmun 2006;26:146-153 (Pubitemid 43138885)
6. Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 2004;4:5. (Pubitemid 39258908)
7. Keltner JL Thirkill CE. Cancer-associated retinopathy vs. recoverin-associated retinopathy. Am J Ophthalmol 1998;126:296-302.
8. Adamus G. Antirecoverin antibodies and autoimmune retinopathy. Arch Ophthalmol 2000;118:1577-1578
9. Visser LH, Schmitz PI, Meulstee J, et al. Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange: Dutch Guillain-Barré Study Group. Neurology 1999;53:598-604.
10. Hooks JJ, Tso MO, Detrick B. Retinopathies associated with antiretinal antibodies. Clin Diagn Lab Immunol 2001;8:853-858
11. Jabs DA, Rosenbaum JT. Guidelines for the use of immuno-suppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2001;131:679.
12. Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol 1999;117:471-477 (Pubitemid 29169641)
13. Dalakas MC. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol Ther 2004;102:177-193
14. Qureshi AI, Choudhry MA, Akbar MS, et al. Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis. Neurology 1999;52:629-632 (Pubitemid 29075617)
15. Federico P, Zochodne DW, Hahn AF, et al. Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology 2000;55(9):1256-1262 (Pubitemid 30829363)
16. Smith AJ, Jackson MW, Wang F, et al. Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome. Hum Immunol 2005;66:411-416 (Pubitemid 40615797)
17. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558 (Pubitemid 34539104)
18. Rush JA, Kennerdell JS, Martinez AJ. Primary idiopathic inflammation of the optic nerve. Am J Ophthalmol 1982;93:312-316
19. Dutton JJ, Burde RM, Klingele TG. Autoimmune retrobulbar optic neuritis. Am J Ophthalmol 1982;94:11-17
20. Jabs DA, Miller NR, Newman SA, et al. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol 1986;104:564-568 (Pubitemid 16086345)
21. Kupersmith MJ, Burde RM, Warren FA, et al. Autoimmune optic neuropathy: evaluation and treatment. J Neurol Neurosurg Psychiatry 1988;51:1381-1386
22. Riedel P, Wall M, Cannon T, et al. Autoimmune optic neuropathy. Arch Ophthalmol 1998;116:1121-1124
23. Frohman LP, Cook SD, Bielory L. Dysgammaglobulinemia in steroid-dependent optic neuritis: response to gammaglobulin treatment. J Clin Neuroophthalmol 1991;11:241-245
24. Whitcup SM, Vistica BP, Milam AH, et al. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol 1998;126:230-237
25. Peek R, Verbraak F, Coevoet HM, et al. Müller cell-specific autoantibodies in a patient with progressive loss of vision. Invest Ophthalmol Vis Sci 1998;39:1976-1979 (Pubitemid 28397282)
26. Keltner JL, Thirkill CE. The 22-kDa antigen in optic nerve and retinal diseases. J Neuroophthalmol 1999;19:71-83. (Pubitemid 30250053)
27. Shimazaki K, Jirawuthiworavong GV, Heckenlively JR, et al. Frequency of anti-retinal antibodies in normal human serum. J Neuroophthalmol 2008;28:5-11.
28. Meek B, Speijer D, De Jong PT, et al. The ocular humoral immune response in health and disease. Prog Retin Eye Res 2003;22:391-415. (Pubitemid 38352554)
29. Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol 2003;48:12-38.
30. Steffen H, Menger N, Richter W, et al. Immune-mediated retinopathy in a patient with stiff-man syndrome. Graefes Arch Clin Exp Ophthalmol 1999;237:212-219 (Pubitemid 29134597)
31. Yanagi Y, Eguchi R, Obata R, et al. Autoimmune retinopathy after chronic renal allograft rejection. Arch Ophthalmol 2006;124:418-420
32. Kurz D, Egan RA, Rosenbaum JT. Treatment of corticosteroid dependent optic neuropathy with intravenous immunoglobulin. Am J Ophthalmol 2005;140:1132-1133 (Pubitemid 41821309)
33. Burt R, Loh Y, Pearce W, et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008;299:925-936
34. Burt RK, Traynor A, Statkute L, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006;295:527-535 (Pubitemid 43200347)
35. Burt RK, Marmont A, Oyama Y, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006;54:3750-3760 (Pubitemid 44955875)
36. Statkute L, Verda L, Oyama Y, et al. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing. Bone Marrow Transplant 2007;39:317-329
37. Voltarelli JC, Couri CE, Stracieri AB, et al. Autologous non-myeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007;297:1568-1576 (Pubitemid 46588370)
38. Pockley AG, Shepherd J, Corton JM. Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol Invest 1998;27:367-377 (Pubitemid 28531057)
39. Adamus G, Amundson D, Siegel GM, et al. Anti-enolase- autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells. J Autoimmun 1998;11:671-677 (Pubitemid 29016125)
40. Stanford MR, Robbins J, Kasp E, et al. Passive administration of antibody against retinal S-antigen induces electroretinographic supernormality. Invest Ophthalmol Vis Sci 1992;33:30-35
41. Ohguro H, et al. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci 1999;40(13):3160-3167
42. Adamus G, Machnicki M, Seigel GM. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1997;38:283-291 (Pubitemid 27085684)
43. Adamus G, Machnicki M, Elerding H, et al. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun 1998;11:523-533 (Pubitemid 28520211)
44. Thirkill CE, Tait RC, Tyler NK, et al. The cancer associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci 1992;33:2768-2772
45. Ko MW, Dalmau J, Galetta SL. Neuro-ophthalmologic manifestations of paraneoplastic syndromes. J Neuroophthalmol 2008;28: 58-66
46. Margolin E, Flint A, Trobe JD. High-titer collapsin response-mediating protein-associated (CRMP-5) paraneoplastic optic neuropathy and vitritis as the only clinical manifestations in a patient with small cell lung carcinoma. J Neuroophthalmol 2008;28: 17-22.